Novartis Genomics Institute to Develop Assays with Q3DM | GenomeWeb

NEW YORK, Dec. 13 — Q3DM will collaborate with the Genomics Institute of the Novartis Research Foundation in order to develop multiple assays on its high-throughput microscopy platform, the company said Thursday.

The company and the institute will jointly develop a suite of applications for high-throughput cell-based screening, and develop for commercialization a set of assays, reagents, and software products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.